<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Roswell Park Cancer Institute | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/roswell+park+cancer+institute.html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Roswell Park Cancer Institute]]></description>
	<s:counts start="0" returned="6" found="6" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Callisto Pharmaceuticals Clinical Study of Anti-Leukemia Drug L-Annamycin Expanded to Third Clinical Site; Roswell Park Cancer Institute Commences Enrollment of Adult Leukemia Patients in Phase I/IIa Clinical Trial]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_March_21/ai_n26800339]]></link>
		<description><![CDATA[NEW YORK -- Callisto Pharmaceuticals, Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, today announced the expansion of its ongoing research trial of L-Annamycin, the Company's drug candidate to treat adult patients with relapsed or refractory acute lymphocytic leukemia...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 21 Mar 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/callisto+pharmaceuticals+inc..html"><![CDATA[Callisto Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/roswell+park+cancer+institute.html"><![CDATA[Roswell Park Cancer Institute]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KAL</category>
		<category domain="tickers">KAL</category>
	</item>
	<item>
		<title><![CDATA[GlycoGenesys Initiates Additional Prestigious Medical Site for GCS-100 Phase I/II Multiple Myeloma Clinical Trial; Patient Screening Begins at Roswell Park Cancer Institute]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Nov_17/ai_n15857396]]></link>
		<description><![CDATA[BOSTON -- GlycoGenesys, Inc. (NASDAQ:GLGS), a biotechnology company, today announced it has initiated Roswell Park Cancer Institute, RPCI Buffalo, New York as a clinical site for its Phase I/II dose escalation trial in patients with multiple myeloma, the second most common blood cancer. The trial is designed to evaluate the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 17 Nov 2005 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/roswell+park+cancer+institute.html"><![CDATA[Roswell Park Cancer Institute]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Roswell Park Cancer Institute Awards Advertising Account to Bandujo, Donker & Brothers]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_April_13/ai_n13605956]]></link>
		<description><![CDATA[NEW YORK -- Bandujo, Donker & Brothers Advertising, New York, NY has been named agency of record by Roswell Park Cancer Institute, a National Cancer Institute designated comprehensive cancer center located in Buffalo, New York. Financial terms and billings were not disclosed.  The world's first cancer research center, Roswell...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 13 Apr 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/roswell+park+cancer+institute.html"><![CDATA[Roswell Park Cancer Institute]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[CANCER RESEARCH PROJECT.(Roswell Park Cancer Institute, University of Puerto Rico agree on cancer research project)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6634/is_200401/ai_n26491106]]></link>
		<description><![CDATA[Roswell Park Cancer Institute is collaborating with the University  of Puerto Rico on a project to increase the number of minority  scientists engaged in cancer research, reports American City Business  Journals (Nov. 25, 2003). The effort is being supported by a three year,  US$506,000 grant by...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Jan 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/roswell+park+cancer+institute.html"><![CDATA[Roswell Park Cancer Institute]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[MRI for Mice, Other Small Creatures.(Roswell Park Cancer Institute)(magnetic resonance imaging)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5834/is_200308/ai_n23801895]]></link>
		<description><![CDATA[AntiCancer Inc. (7917 Ostrow St., San Diego, CA 9211 Tel: 619/654-  2555, 619/268-4175) and Roswell Park Cancer Institute (Elm and Carlton  Streets, Buffalo, NY 14263,  Tel: 716/845-2300, Website:  roswellpark.org). have initiated a collaboration to develop multi-  modality, non-invasive imaging in small animal models of human...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Aug 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/roswell+park+cancer+institute.html"><![CDATA[Roswell Park Cancer Institute]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Roswell Park Cancer Institute.(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5930/is_199908/ai_n23847758]]></link>
		<description><![CDATA[* Researchers at the Roswell Park Cancer Institute, Buffalo, NY,  and the Boyce Thompson Institute for Plant Research at Cornell  University have begun clinical trials of a genetically engineered potato  containing an oral vaccine against hepatitis B.  It is only a fraction  of the cost...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 16 Aug 1999 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/roswell+park+cancer+institute.html"><![CDATA[Roswell Park Cancer Institute]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
